Вabanina N. The clinical basis advisable of combined usage of actoveginy and piracetamy in the treatment of children's cerebral palsy.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0408U005784

Applicant for

Specialization

  • 14.01.28 - Клінічна фармакологія

19-12-2008

Specialized Academic Board

Д 26.550.01

Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine

Essay

Organic defeats CNS children's cerebral paralysis wins first place in structure of diseases of children - invalids, that causes search and development of new approaches to therapy of the given disease. Improvement of display neuron - specific fibers in whey of blood displays influence actovegyn and piracetam on fabric a metabolism. Great value have questions of studying immunology the status at children of early age with cerebral palsy. Due to use actovegyn and piracetam observe immunomodulation the effect, therefore the purpose of work is precise dozes of combined use of these preparations for correction the immune answer.

Files

Similar theses